Marksans Pharma Limited · BSE:MARKSANS
Marksans Pharma Limited shareholders
Marksans Pharma Limited on 6ix: holders from US fund reports. Largest: State Street(R) SPDR(R) Portfolio Emerging Markets ETF, Vanguard Total International Stock Index Fund and Vanguard Emerging Markets Stock Index Fund. Each with its filing.
| Holder | Shares | % of Marksans Pharma Limited | Change | As of |
|---|---|---|---|---|
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF | 3.34M | no change | Jun 30, 2026 | |
| Vanguard Total International Stock Index Fund | 3.14M | +298K | Jul 31, 2026 | |
| Vanguard Emerging Markets Stock Index Fund | 3.05M | no change | Jul 31, 2026 | |
| iShares Core MSCI Emerging Markets ETF | 2.09M | +89,392 | May 31, 2026 | |
| Emerging Markets Core Equity 2 Portfolio | 1.89M | no change | Jul 31, 2026 | |
| Dimensional Emerging Markets Value Fund | 930K | −36,034 | Jul 31, 2026 | |
| Vanguard Ftse All-World Ex-Us Small-Cap Index Fund | 845K | no change | Jul 31, 2026 | |
| The Emerging Markets Small Cap Series | 632K | no change | Jul 31, 2026 | |
| iShares MSCI India Small-Cap ETF | 408K | −23,105 | May 31, 2026 | |
| WisdomTree India Earnings Fund | 391K | −23,123 | Jun 30, 2026 |